Fund investment, financing and exits; domestic and cross-border acquisitions; market access, the two-invoice system, centralised procurement, licensing, tax, employment, antitrust and intellectual property matters.
In-licensing and out-licensing, pharmaceutical rights transactions, collaborative R&D, contract manufacturing and research; freedom-to-operate (FTO), patent coverage and validity analysis; anti-corruption and administrative investigations; approvals, registration, distribution, pricing, advertising, imports and recalls.